1. Park M, Park S, Jung WH. Skin Commensal Fungus Malassezia and Its Lipases. J Microbiol Biotechnol. 2021;31: 637-644.
2. Rhimi W, Theelen B, Boekhout T, Otranto D, Cafarchia C. Malassezia spp. Yeasts of Emerging Concern in Fungemia. Front Cell Infect Microbiol 2020; 10:370.
3. Łabędź N, Navarrete-Dechent C, Kubisiak-Rzepczyk H, Bowszyc-Dmochowska M, Pogorzelska-Antkowiak A, Pietkiewicz P. Pityriasis Versicolor-A Narrative Review on the Diagnosis and
Management. Life (Basel). 2023; 13:2097.
4. Takashima M, Sugita T. Taxonomy of Pathogenic Yeasts Candida, Cryptococcus, Malassezia, and Trichosporon. Med Mycol J. 2022; 63: 119-132.
5. Kantarcıoğlu SA, Yücel A. Malassezia species: Taxonomy, mycology, immunology, pathogenesis, distribution and related infections, laboratory diagnosis, antifungal susceptibility. Cerrahpaşa
J Med 2005; 36: 134-154.
6. Vijaya Chandra SH, Srinivas R, Dawson TL Jr and Common JE (2021) Cutaneous Malassezia: Commensal, Pathogen, or Protector? Front. Cell Infect Microbiol 10:614446.
7. Grice, E.A.; Dawson, T.L. Host–microbe interactions: Malassezia and human skin. Curr Opin Microbiol 2017; 40, 81–87.
8. Mostafa, W.Z.; Assaf, M.I.; Ameen, I.A.; El Safoury, O.S.; Al Sulh, S.A. Hair loss in pityriasis versicolor lesions: A descriptive clinicopathological study. J Am Acad Dermatol 2013, 69, e19–e23.
9. Leung, A.K.; Barankin, B.; Lam, J.M.; Leong, K.F.; Hon, K.L. Tinea versicolor: An updated review. Drugs Context 2022, 11.
10. Schwartz RA. Superficial fungal infections. Lancet. 2004; 364: 1173-82.
11. Kiken DA, Sekaran A, Antaya RJ, Davis A, Imaeda S, Silverberg NB. White piedra in children. J Am Acad Dermatol. 2006; 55:956-61.
12. Gaurav V, Grover C, Das S, Rai G. White Piedra: An Uncommon Superficial Fungal Infection of Hair. Skin Appendage Disord. 2022; 8: 34-37.
13. Bonifaz A, Tirado-Sánchez A, Araiza J, Rodríguez-Leviz A, Guzmán-Sánchez D, Gutiérrez-Mendoza S, Castrejón L. White Piedra: Clinical, Mycological, and Therapeutic Experience of
Fourteen Cases. Skin Appendage Disord. 2019; 5:135-141.
14. Mehta V, Nayyar C, Gulati N, Singla N, Rai S, Chandar J. A Comprehensive Review of Trichosporon spp.: An Invasive and Emerging Fungus. Cureus. 2021; 13: e17345.
15. Montoya AM, Gonzáleza GM. Trichosporon spp.: an emerging fungal pathogen. Medicana Universitaria. 2014; 16: 37-43p.
16. Singh A, Nyati A, Mohta A, Kushwaha RK, Jain SK. A Case of Scalp White Piedra Caused by Trichosporon ovoides. Int J Trichology 2019; 11: 134-137.
17. Macedo PM, Freitas DFS. Superficial Infections of the Skin and Nails. Encyclopedia of Mycology.2020; 707-718.
18. Sharma P, Nassereddin A, Sonthalia S. Black Piedra. [Updated 2023 Feb 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www.ncbi.
nlm.nih.gov/books/NBK545178/.
19. Prieto-Granada, C. N., Lobo, A. Z. C., & Mihm, M. C. (2010). Skin Infections. Diagnostic Pathology of Infectious Disease, 560–580.
20. Kelarestaghi A, Hashemi SJ, Rafat Z, Kelarestaghi H, Moqaddam ZR, Maboudi A, Khodavaisy S. The first report of tinea nigra from Iran. New Microbes New Infect. 2022; 49-50: 101032.
21. Liao YC, Hsieh MI, Chao SC, Wu CJ. Tinea nigra due to Hortaea werneckii in Taiwan. J Microbiol Immunol Infect. 2022; 55: 558-560.
22. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995;8: 240-259.
23. de Hoog GS, Dukik K, Monod M, et al. Toward a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia 2017; 182:5-31.
24. de Hoog S, Monod M, Dawson T, et al. Skin fungi from colonization to infection. Microbiol Spectr 2017;5(4):10.1128./microbiolspec.funk-0049-2016.
25. Chanyachailert P, Leeyaphan C, Bunyaratavej S. Cutaneous fungal infections caused by dermatophytes and non-dermatophytes: An updated comprehensive review of epidemiology, clinical presentati-
ons, and diagnosting testing. J Fungi 2023,9,669.
26. Kruitgoff C, Gamal A, McCormick TS, Ghannoum MA. Dermatophyte infections Worldwide: Increase in incidence and associated antifungal resistance. Life 2024; 14: 1-13.
27. Wang R, Huang C, Zhang Y, Li R. Invasive dermatophyte infection: A systematic review. Mycoses 2021;64:340-348.
28. Delliere S, Jabet A, Abdolrasouli A. Current and emerging issues in dermatophyte infections. PLoS Pathog 2024;20(6):e1012258.
29. Zhan P, Liu W. The changing face of dermatophytic infections Worldwide. Mycopathologia 2017; 182:77-86.
30. Moskaluk AE, VandeWoude S. Current topics in dermatophyte classification and clinical diagnosis. Pathogens 2022; 11:957.
31. Metin B, Heitman J. Sexual reproduction in dermatophytes. Mycopathologia 2017;182:45-55.
32. Metin B, Heitman J. She loves me, she loves me not; Sexual nature of dermatophyte fungi. Mycopathologia 2020; 185:87-101.
33. de Hoog GS, Guarro J, Gene J, Ahmed SA, Al-Hatmi AMS, Figueras MJ, Vitale RG. Atlas of Clinical Fungi. 4th edition. Foundation Atlas of Clinical Fungi, Hilversum; 2021.
34. Wallsh TH, Hayden RT, Larone DH. Larone’s Medically İmportant Fungi: A Guide to İdentification. 6th edition. New York; ASM Pres, 2018.
35. Graser Y, Monod M, Bouchara JP, et al. New insights in dermatophyte research. Med Mycol 2018; 56 (Suppl 1): S2–S9.
36. Martinez-Rossi NM, Peres NTA, Bitencourt TA, et al. State-of-the-Art dermatophyte infections: Epidemiology aspects, pathophysiology, and resistance mechanisms. J Fungi 2021;7(8):629.
37. Hill RC, Caplan AS, Elewski B, et al. Expert panel review of skin and hair dermatophytoses in an era of antifungal resistance. Am J Clin Dermatol 2024; 25:359–389.
38. Wijayaweardene NN, Hyde KD, Rajeshkumar KC, et al. Notes for Genera; Ascomycota. Fungal Diversity 2017; 86:1-594.
39. Zhang ZY, Han YF, Chen WH, Liang ZQ. Phylogeny and taxonomy of three new Ctenomyces new Ctenomyces (Arthrodermataceae, Onygenales) species from China. MycoKeys 2019; 47:1-16.
40. Petrucelli MF, de Abreu MH, Cantelli BAM, et al. Epidemiology and diagnostic perspectives of dermatophytoses. J Fungi 2020,6,310
41. Barac A, Stjepanovic M, Krajisnik S, et al. Dermatophytes: Update on clinical epidemiology and treatment. Mycopathologia 2024; 189:101
42. Gupta AK, Wang T, Mann A, et al. Antifungal resistance in dermatophytes – review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae
infections. Expert Rev Anti-Infect Ther 2024; 22:739-751.
43. Ferreira CB, Lisboa C. A systematic review on the emergence of terbinafine-resistant Trichophyton indotineae in Europe: Time to act? JEADV 2025; 39:364-376.
44. Durdu M, Kandemir H, Karakoyun AS, et al. First terbinafine-resistant Trichophyton indotineae isolates with Phe397Leu and/or Thr414His mutations in Turkey. Mycopathologia 2023;
188:295-304.
45. Jabet A, Bérot V, Chiarabini T, et al. Trichophyton mentagrophytes ITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon. J Eur Acad Dermatol
Venereol. 2025; 39:407-415.
46. Jartarkar SR, Patil A, Grabbe S, et al. Pathogenesis, immunology and management of dermatophytosis. J Fungi 2022,8,39.
47. Celestrino GA, Verrinder Veasey J, Benard G, Sousa MGT. Host immune responses in dermatophytes infection. Mycoses. 2021; 64:477-483.
48. Elewski BE, Alabama B. Tinea capitis: A current perspective. J Am Acad Dermatol 2000;42: 1-20.
49. Gupta AK, Friedlander SF, Simkovich AJ. Tinea capitis: An update. Pediatric Dermatology 2022; 39:167–172.
50. Hill RC, Gold JAW, Lipner SR. Comprehensive review of Tinea capitis in adults: Epidemiology, risk factors, clinical presentations, and management. J Fungi 2024,10,357.
51. Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007;50(Suppl 2):6-13.
52. Gupta AK, Ravi SP, Wang T, et al. An update on tinea capitis in children. Pediatr Dermatol 2024;41: 1030-1039.
53. Leung AKC, Lam JM, Leong KF, et al. Onychomycosis: An updated review. Recent Patents on Inflammation & Allergy Drug Discovery 2020; 14: 32-45.
54. Lipner SR, Scher RK. Onychomycosis. Clinical overview and diagnosis. J Am Acad Dermatol 2019; 8:835-851.
55. Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive? Indian Dermatol Online J 2016; 7: 73-76.
56. Khan SS, Hay R, Saunte DML. An international survey of recalcitrant and recurrent tinea of the glabrous skin—A potential indicator of antifungal resistance. J Eur Acad Dermatol Venereol
2024; 39:1185–1191.
57. Gupta AK, Ravi SP, Wang T, et al. Antifungal resistance, susceptibility testing and treatment of recalcitrant dermatophytosis caused by Trichophyton indotineae: A North American perspective
on management. Am J Clin Dermatol 2023; 24:927–938.
58. Gupta AK, Talukder M, Carviel JL, Cooper EA, Piguet V. Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis. J Eur
Acad Dermatol Venereol 2023; 37:1706–1717.
59. Gupta AK, Wang T, Mann A, et al. Antifungal resistance in dermatophytes – review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae
infections. Expert Review of Anti-infective Therapy 2024; 22: 739- 751.
60. Kidd SE, Weldhagen GF. A Diagnosis of dermatophytes: from microscopy to direct PCR. Microbiology Australia 2022;43: 9–13.
61. Robert R, Pihet M. Conventional methods for the diagnosis of dematophytosis. Mycopathologia 2008; 166:29–3065.
62. Bidaud A-L, Normand A-C, Jabet A, et al. Reliability of a terbinafine agar containing method for the screening of dermatophyte resistance. Med Mycol 2023, 61, myad043.
63. Aksoy H, Gurel MS, Sarmış A, Aslan M. Effect of finger socks on clinical cure in interdigital tinea pedis. J Am Acad Dermatol 2025; 92:1032-1038.
64. Gupta AK, Hall DC, Cooper EA, Ghannoum MA. Diagnosing onychomycosis: What’s new? J Fungi 2022, 8, 464.
65. Gupta AK, Talukder M, Shemer M, Galili E. Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis. Expert
Review of Anti-infective Therapy 2024; 22: 399-412.